Fengguo Xu

机构：China Pharmaceutical University, Jiangning District of Nanjing Chinese Medicine Hospital, State Key Laboratory of Natural Medicine · ORCID：0000-0001-9999-0128

发表论文 156 篇 · 总被引 4259 次 · h-index 36

代表论文

• Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer (2025 · Advanced Science · 被引 20)
• A chemical derivatization-based pseudotargeted LC-MS/MS method for high coverage determination of dipeptides (2023 · Analytica Chimica Acta · 被引 16)
• High-Coverage Strategy for Multi-Subcellular Metabolome Analysis Using Dansyl-Labeling-Based LC-MS/MS (2023 · Analytical Chemistry · 被引 15)
• Sensitive quantification of mevalonate pathway intermediates and prediction of relative novel analogs by chemical derivatization-based LC-MS/MS (2024 · Journal of Chromatography A · 被引 8)
• Combined gut microbiome and metabolomics to reveal the mechanism of proanthocyanidins from the roots of Ephedra sinica Stapf on the treatment of ulcerative colitis (2024 · Journal of Pharmaceutical and Biomedical Analysis · 被引 7)
• The novel combination of astragaloside IV and formononetin protects from doxorubicin-induced cardiomyopathy by enhancing fatty acid metabolism (2025 · Chinese Journal of Natural Medicines · 被引 5)